Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMD vs MRNA✓SelectedUSD · MRNAAMD vs MRNA performance historyLatest closeAs of+5.31%11/18
Stock and ETF performance explorer

AMD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+242.0%
MRNA return
-20.0%
Excess return
+262.0%
Maximum drawdown
-65.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+5.3%-4.8%+10.2%+5.7%
7D-4.1%-20.9%+16.8%-2.2%
30D-1.5%-13.3%+11.8%-0.2%
3M+9.4%+212.6%-203.1%-8.5%
6M+25.9%+309.0%-283.1%-2.9%
YTD+147.5%+567.3%-419.8%+68.4%
1Y+130.2%+689.7%-559.5%+50.1%
3Y+339.5%+157.4%+182.1%+238.5%
5Y+242.0%-21.7%+263.7%+208.6%
All+242.0%-20.0%+262.0%+208.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling